Inventor · disambiguated record
Ningyan Zhang
Also filed as: ZHANG NINGYAN
21 granted patents·21 pending applications·24 citations·filing 2009–2025
92Inventor score
Files withUNIV TEXAS34ACUMEN PHARMACEUTICALS INC3MERCK SHARP & DOHME2ASTE-AMEZAGA JOSE MIGUEL1GASPAR RENEE C1
Top patents by PatentIndex Score
42 records- 0188US10501538B2Anti-LILRB antibodies and their use in detecting and treating cancerUNIV TEXAS·Filed 2017·Granted Dec 10, 2019·5 cites·24 claims
- 0286US10875912B2EGFL6 specific monoclonal antibodies and methods of their useUNIV TEXAS·Filed 2017·Granted Dec 29, 2020·2 cites·9 claims
- 0385US12202895B2LILRB4 antibodies and uses thereofUNIV TEXAS·Filed 2019·Granted Jan 21, 2025·2 cites·42 claims
- 0485US11912758B2Methods of treating metastasis, including inhibiting bone cancer metastasis, by administering an antibody which binds connexin 43 (Cx43) hemichannelUNIV TEXAS·Filed 2021·Granted Feb 27, 2024·1 cites·20 claims
- 0585US2025145702A1Egfl6 specific monoclonal antibodies and methods of their useUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0683US12503500B2Connexin 43 (Cx43) hemichannel-binding antibodiesUNIV TEXAS·Filed 2024·Granted Dec 23, 2025·0 cites·8 claims
- 0782US12037390B2Leptin antibodies and method of reducing leptinUNIV TEXAS·Filed 2023·Granted Jul 16, 2024·0 cites·4 claims
- 0881US9725520B2HER3 specific monoclonal antibodies for diagnostic and therapeutic useUNIV TEXAS·Filed 2014·Granted Aug 8, 2017·4 cites·18 claims
- 0979US10358501B2HER3 specific monoclonal antibodies for diagnostic and therapeutic useUNIV TEXAS·Filed 2017·Granted Jul 23, 2019·2 cites·25 claims
- 1078US10889637B2Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodiesUNIV TEXAS·Filed 2017·Granted Jan 12, 2021·2 cites·10 claims
- 1177US9309309B2Anti-ADDL monoclonal antibody and uses thereofMERCK SHARP & DOHME·Filed 2014·Granted Apr 12, 2016·3 cites·10 claims
- 1273US12152071B2EGFL6 specific monoclonal antibodies and methods of their useUNIV TEXAS·Filed 2020·Granted Nov 26, 2024·0 cites·5 claims
- 1372US12331130B2DDR1 antibodies and uses thereofUNIV TEXAS·Filed 2023·Granted Jun 17, 2025·0 cites·13 claims
- 1471US11174320B2HER3 specific monoclonal antibodies for diagnostic and therapeutic useUNIV TEXAS·Filed 2019·Granted Nov 16, 2021·0 cites·20 claims
- 1570US11760799B2Leptin antibodiesUNIV TEXAS·Filed 2020·Granted Sep 19, 2023·0 cites·4 claims
- 1668US11377491B2Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancerUNIV TEXAS·Filed 2018·Granted Jul 5, 2022·1 cites·10 claims
- 1767US2025250336A1Novel lilrb4 antibodies and uses thereofUNIV TEXAS·Filed 2025·Application pending·0 cites
- 1865US11498963B2Anti-LILRB antibodies and their use in detecting and treating cancerUNIV TEXAS·Filed 2019·Granted Nov 15, 2022·0 cites·15 claims
- 1965US9320793B2Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42ACUMEN PHARMACEUTICALS INC·Filed 2012·Granted Apr 26, 2016·1 cites·1 claims
- 2064US9310383B2Antibodies, kit and method for detecting amyloid beta oligomersACUMEN PHARMACEUTICALS INC·Filed 2015·Granted Apr 12, 2016·1 cites·8 claims
- 2163US12331110B2Monoclonal antibodies against endotrophin and the use thereofUNIV TEXAS·Filed 2019·Granted Jun 17, 2025·0 cites·14 claims
- 2263US2025270312A1Monoclonal antibodies against endotrophin and the use thereofUNIV TEXAS·Filed 2025·Application pending·0 cites
- 2362US2024376199A1Trem2 antigen binding proteins and uses thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2462US2024376222A1Tfr antigen binding proteins and uses thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2560US2024392001A1Lilrb2-specific monoclonal antibodies and methods of their useUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2659US2025172557A1Methods for identifying lilrb ligands and blocking antibodiesUNIV TEXAS·Filed 2023·Application pending·0 cites
- 2758US2023130372A1Novel ddr1 antibodies and uses thereofUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2857US2011286916A1Generation and characterization of anti-notch antibodies for therapeutic and diagnostic useASTE-AMEZAGA JOSE MIGUEL·Filed 2009·Application pending·0 cites
- 2956US2022267415A1Multimeric sars-cov-2 binding molecules and uses thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 3054US2023348586A1Therapeutic agents and uses thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 3154US2025262315A1Tripeptide linkers and methods of use thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 3252US11906519B2Methods for identifying LILRB-blocking antibodiesUNIV TEXAS·Filed 2017·Granted Feb 20, 2024·0 cites·26 claims
- 3352US2024101667A1Methods for identifying lilrb-blocking antibodiesUNIV TEXAS·Filed 2021·Application pending·0 cites
- 3451US2023235055A1Monoclonal antibodies against lilrb1 for diagnostic and therapeutic useUNIV TEXAS·Filed 2021·Application pending·0 cites
- 3550US2025197513A1Osmr-specific monoclonal antibodies and methods of their useUNIV TEXAS·Filed 2022·Application pending·0 cites
- 3650US2024383999A1Cd5l-binding antibodies and uses for the sameUNIV TEXAS·Filed 2021·Application pending·0 cites
- 3750US2023399384A1Antibodies to coronavirus spike protein and methods of use thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 3847US2015320860A1Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42ACUMEN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3946US2021371508A1Nmes1 antibodies and methods of use thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 4043US2013115227A1Anti-addl monoclonal antibody and uses thereofGASPAR RENEE C·Filed 2011·Application pending·0 cites
- 4140US11230591B2CMV neutralizing antigen binding proteinsMERCK SHARP & DOHME·Filed 2017·Granted Jan 25, 2022·0 cites·17 claims
- 4238US2012195831A1Generation, characterization and uses thereof of anti-her3 antibodiesZHANG NINGYAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ningyan Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →